Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lund

Showing results (571-580 of 826) with videos related to

Pageof 83
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2005
Stable X chromosome inactivation involves the PRC1 Polycomb complex and requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3 ligaseInmaculada Hernández-Muñoz, Anders H Lund, Petra van der Stoop, et al.
European Journal of Heart Failure|June 29, 2021
Cardiac, renal, and metabolic effects of sodium-glucose co-transporter 2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium-glucose co-transporter 2 inhibitorsWilliam G Herrington, Gianluigi Savarese, Richard Haynes, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 1, 2016
Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation RegistryOmar Wever-Pinzon, Leah B Edwards, David O Taylor, et al.
Oncogene|July 23, 2013
Prdm5 suppresses Apc(Min)-driven intestinal adenomas and regulates monoacylglycerol lipase expressionG G Galli, H A Multhaupt, M Carrara, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 27, 2007
Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetesA M W Spijkerman, M-A Gall, L Tarnow, et al.
ESC Heart Failure|November 29, 2023
Acyl ghrelin increases cardiac output while preserving right ventricular-pulmonary arterial coupling in heart failureMikael Erhardsson, Ulrika L Faxén, Ashwin Venkateshvaran, et al.
European Journal of Heart Failure|May 2, 2024
Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure RegistryAmerigo Ferrari, Davide Stolfo, Alicia Uijl, et al.
Internal Medicine Journal|May 17, 2005
Cisplatin and gemcitabine induction chemotherapy followed by concurrent chemoradiotherapy or surgery for locally advanced non-small cell lung cancerM J Byrne, M Phillips, A Powell, et al.
European Heart Journal|April 1, 2026
Heart failure with reduced ejection fraction in Sweden: patient adherence and persistence to quadruple pharmacotherapy prescriptionFelix Lindberg, Alicia Uijl, Lina Benson, et al.
European Heart Journal|March 14, 2023
Acyl ghrelin improves cardiac function in heart failure and increases fractional shortening in cardiomyocytes without calcium mobilizationLars H Lund, Camilla Hage, Gianluigi Pironti, et al.
Pageof 83

Showing results (571-580 of 826) with videos related to

Sort By:
Pageof 83
Proceedings of the National Academy of Sciences of the United States of America|May 18, 2005
Stable X chromosome inactivation involves the PRC1 Polycomb complex and requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3 ligaseInmaculada Hernández-Muñoz, Anders H Lund, Petra van der Stoop, et al.
European Journal of Heart Failure|June 29, 2021
Cardiac, renal, and metabolic effects of sodium-glucose co-transporter 2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium-glucose co-transporter 2 inhibitorsWilliam G Herrington, Gianluigi Savarese, Richard Haynes, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 1, 2016
Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation RegistryOmar Wever-Pinzon, Leah B Edwards, David O Taylor, et al.
Oncogene|July 23, 2013
Prdm5 suppresses Apc(Min)-driven intestinal adenomas and regulates monoacylglycerol lipase expressionG G Galli, H A Multhaupt, M Carrara, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 27, 2007
Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetesA M W Spijkerman, M-A Gall, L Tarnow, et al.
ESC Heart Failure|November 29, 2023
Acyl ghrelin increases cardiac output while preserving right ventricular-pulmonary arterial coupling in heart failureMikael Erhardsson, Ulrika L Faxén, Ashwin Venkateshvaran, et al.
European Journal of Heart Failure|May 2, 2024
Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure RegistryAmerigo Ferrari, Davide Stolfo, Alicia Uijl, et al.
Internal Medicine Journal|May 17, 2005
Cisplatin and gemcitabine induction chemotherapy followed by concurrent chemoradiotherapy or surgery for locally advanced non-small cell lung cancerM J Byrne, M Phillips, A Powell, et al.
European Heart Journal|April 1, 2026
Heart failure with reduced ejection fraction in Sweden: patient adherence and persistence to quadruple pharmacotherapy prescriptionFelix Lindberg, Alicia Uijl, Lina Benson, et al.
European Heart Journal|March 14, 2023
Acyl ghrelin improves cardiac function in heart failure and increases fractional shortening in cardiomyocytes without calcium mobilizationLars H Lund, Camilla Hage, Gianluigi Pironti, et al.
Pageof 83